Consuelo Wilkins Archive
-
February 20, 2020
5 highlights from Leadership Assembly
A focus on bolstering and supporting the people who put the “personal” in personalized care is fueling initiatives around Vanderbilt University Medical Center as leaders look to boost connectivity of an expanding workforce that’s taking on more patients in a rapidly changing environment. -
October 18, 2018
Translational Research Forum set for Oct. 26
Patricia Griffin, MD, chief of the Enteric Diseases Epidemiology Branch at the U.S. Centers for Disease Control and Prevention (CDC), will be the guest speaker at the 2018 Vanderbilt Translational Research Forum Oc. 26 at the Vanderbilt Student Life Center. -
July 19, 2018
Grant to develop ways to measure medical mistrust in African-American men
Vanderbilt University Medical Center has been awarded a two-year, $250,000 grant by The Robert Wood Johnson Foundation to develop new ways to measure trust in African-American men as it relates to health care. -
June 28, 2018
Vanderbilt thinkers come together for StrategyShare18
Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives. -
April 26, 2018
Wilkins takes key role in national ‘All of Us’ precision medicine effort
Consuelo Wilkins, MD, MSCI, has played a major role in the development of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine. -
October 26, 2017
Precision medicine discussion
Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture. -
August 17, 2017
Wilkins named to national committee exploring return of research results
Consuelo Wilkins, M.D., MSCI, executive director of the Meharry-Vanderbilt Alliance, has been appointed to a national committee charged with determining how best to return to research participants the results of studies of their blood and other bio-specimens.